Bronchial hyperreactivity in patients with mitral stenosis before and after successful percutaneous mitral balloon valvulotomy

Citation
S. Gulec et al., Bronchial hyperreactivity in patients with mitral stenosis before and after successful percutaneous mitral balloon valvulotomy, CHEST, 116(6), 1999, pp. 1582-1586
Citations number
22
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CHEST
ISSN journal
00123692 → ACNP
Volume
116
Issue
6
Year of publication
1999
Pages
1582 - 1586
Database
ISI
SICI code
0012-3692(199912)116:6<1582:BHIPWM>2.0.ZU;2-J
Abstract
Objectives: We aimed to identify the bronchial response to inhaled methacho line in patients with mitral stenosis (MS) and to clarify whether or not th e bronchial hyperreactivity (BHR) is reversible after percutaneous mitral b alloon valvulotomy (PBMV). Patients and setting: Thirty patients with MS and 28 age-matched healthy! c ontrol subjects were prospectively evaluated with pulmonary function tests and methacholine challenge. The productive concentration of methacholine ca using 20% decrease in FEV1 (PC20) was calculated and used as a parameter of bronchial responsiveness, BHR was defined as a PC20 < 8 mg/mL, Mean pulmon ary artery pressure (PAP) and mean pulmonary capillary wedge pressure (PCWP ) were recorded in all patients through a Swan-Ganz balloon-tipped catheter . Sixteen patients underwent PMBV, and a methacholine test was repeated aft er each procedure. Results: Bronchial response to methacholine was significantly increased in patients with MS, so that 53% of them had BHR, whereas all control subjects were nonresponders. The PC,, was closely correlated with the PAP (r = -0.7 77; p < 0.001), PCWP (r = - 0.723; p < 0.001), and I mitral valve area (MVA ; r = 0.676; p < 0.001). Balloon valvulotomy was successfully performed in i all of the 16 patients, and the cardiac parameters (MVA, PAP, and PCWP) s ignificantly improved after the procedure, In contrast, no significant chan ges were shown in pulmonary function test variables (total lung capacity, v ital capacity [VC], FEVI, and FEVI/VC). Although significant improvement wa s observed in the mean PC20 values (from 4.97 +/- 5.24 to 7.47 +/- 6.96 mg/ mL; p 0.0006), BHR was completely eliminated in only one patient, Conclusions: Our data shows that BHR is fairly common among patients with M S, and severity of bronchial responsiveness is significantly correlated nit h the severity of MS, Moreover, PMBV leads to significant I eduction in pul monary congestion and a consequent improvement in BHR.